Side Effects Observed in Initial HRO761 Clinical Trials | Categorical | | | 8 months ago | |
Phase Progress of HRO761 Clinical Trials by 2025 | Categorical | | | 8 months ago | |
FDA Fast Track Designation for HRO761 by End of 2024 | Binary | | | 8 months ago | |
HRO761 Effectiveness in Phase 1 Trials by End of 2025 | Binary | | | 8 months ago | |
HRO761 Phase 1 Clinical Trials Approval by End of 2024? | Binary | | | 8 months ago | |
HRO761 Shows Over 50% Effectiveness in Phase 1 Trials | Binary | | | 8 months ago | |
Expansion of Cancer Targets for HRO761 by End of 2025 | Categorical | | | 8 months ago | |
Clinical Trial Phase for HRO761 by End of 2026 | Categorical | | | 8 months ago | |
HRO761 Phase 1 Clinical Trial Approval by End of 2024 | Binary | | | 8 months ago | |
Most Responsive Cancer Type to HRO761 in Phase 1 Trials by End of 2025 | Categorical | | | 8 months ago | |
Number of New Collaborative Partners for HRO761 Research by End of 2025 | Categorical | | | 8 months ago | |
Type of Partnership for HRO761 Development by End of 2024 | Categorical | | | 8 months ago | |
Completion of Phase 1 Trials for HRO761 by 2025 | Binary | | | 8 months ago | |
HRO761 Exhibits Over 30% Efficacy in Phase 1 Trials by 2025 | Binary | | | 8 months ago | |
Publication of HRO761 Initial Clinical Trial Results by Mid-2025 | Binary | | | 8 months ago | |
Publication of Initial HRO761 Clinical Trial Results by End of 2025? | Binary | | | 8 months ago | |
Geographical Regions for HRO761 Phase 1 Trials by End of 2025 | Categorical | | | 8 months ago | |
Number of Partnerships for HRO761 Development by End of 2025 | Categorical | | | 8 months ago | |
